一、基本情况
| 姓名 | 性别 | 出生年月 |
招生专业 |
| ||
| 任秀宝 | 男 | 196604 | ||||
| 专业技术职务 | 行政职务 | |||||
|
教授 主任医师 | 天津市肿瘤免疫与生物 治疗重点实验室主任 生物技术研究室主任 生物治疗科主任 |
肿瘤学 | ||||
|
招生类型 |
所在单位 | |||||
| 科学学位（博）\科学学位（硕）\专业学位（博）\专业学位（硕） | 天津医科大学 肿瘤医院 | |||||
| 最后学历及学位 | ||||||
| 毕业院校 | 毕业时间 | 所学专业 | 所获学位 | |||
| 天津医科大学 | 2006 年 7 月 | 肿瘤学 | 博士学位 | |||
| | 科学研究主要方向 | |||||
| rwziyi@yahoo.com | 肿瘤生物治疗的临床和基础研究 | |||||
二、目前承担科研课题情况
| 项目名称（级别最高 3-5 项） | 项目来源 | 本人排名 | 本人可支配 经费（万） | 项目起止时间 |
| 1 基于纳米技术的肺癌早期检测研究 | 国家 973 项目子课题 | 1 | 641 万 | 2012-2015 |
| 2 抗体产业化关键原材料研发及生产 平台的建立 | 国家 863 计划子课题 | 1 | 200 万 | 2012-2015 |
| 3 乳腺癌髓源性抑制细胞(MDSC)对 B 细 胞功能的影响及调控机制 | 国家自然科学基金 | 1 | 80 万 | 2015-2018 |
| 4 CUL4A 在小细胞肺癌发生发展中的作 用及其调控机制 | 国家自然科学基金 | 1 | 70 万 | 2013-2016 |
| 5 基于 TCR 基因修饰的 T 细胞特异性抗 肿瘤治疗的基础和临床研究 | 国际横向合作 | 1 | 443 万 | 2011-2015 |
三、发表论文论著情况
| 题目 | 刊物或出版社 | 本人排名 | 发表时间 | 收录情况 （SCI、EI） |
| High-mobility group nucleosome-binding protein 1 is a novel clinical biomarker in non-small cell lung cancer. |
Tumour Biol |
通讯作者 |
2015 |
SCI |
| Osteopontin is a novel prognostic biomarker in early stage non small cell lung cancer after surgical resection | J Cancer Res Clin Oncol |
通讯作者 |
2015 |
SCI |
| Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment | Tumor Biol. | 通讯作者 | 2015 | SCI |
| Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer | J Immunol | 通讯作者 | 2014 | SCI |
| The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications. | Int J Cancer | 通讯作者 | 2014 | SCI |
| Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment | J Immunother | 通讯作者 | 2014 | SCI |
| IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells | J Leukoc Biol | 通讯作者 | 2014 | SCI |
| Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. | Gene | 通讯作者 | 2014 | SCI |
| Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. | J Immunol | 通讯作者 | 2013 | SCI |
| Immunotherapy with Cytokine-Induced Killer Cells as an Adjuvant Treatment for Advanced Gastric Carcinoma: A Retrospective Study of 165 Patients. | Cancer Biother Radiopharm | 通讯作者 | 2013 | SCI |
| A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma. | J Clin Immunol | 通讯作者 | 2013 | SCI |
| Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients. | Cancer Immunol Immunother | 通讯作者 | 2013 | SCI |
| The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer. | Dig Dis Sci | 通讯作者 | 2013 | SCI |
| The clinical significance of memory T cells and its subsets in gastric cancer. | Clin Transl Oncol. | 通讯作者 | 2013 | SCI |
| Primary Hepatic Angiosarcoma and Potential Treatment Options. | J Gastroenterol Hepatol | 通讯作者 | 2013 | SCI |
| The role of miRNA-29 family in cancer. | Eur J Cell Biol | 通讯作者 | 2013 | SCI |
| Interferon-λs: special immunomodulatory agents and potential therapeutic targets. | J Innate Immun | 通讯作者 | 2013 | SCI |
| Current Adoptive Immunotherapy in Non-Small Cell Lung Cancer and Potential Influence of Therapy Outcome. | Cancer Investigation | 通讯作者 | 2013 | SCI |
四、主要业绩
